Home › Funds › Tetragon Partners GP Ltd › DFTX

Tetragon Partners GP Ltd position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Tetragon Partners GP Ltd reported holding 286,990 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$13.5M, representing 2.20% of its reported portfolio and ranking #5 among its reported holdings. Tetragon Partners GP Ltd has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)286.99K sh
Reported value held$13.50M
Portfolio Weight2.20%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's DFTX position evolved

Tetragon Partners GP Ltd first disclosed a stake in DFTX in Q1 2026 at 199,994 shares (US$3.8M). The position peaked in Q2 2026 at 286,990 shares, worth US$13.5M. Across 2 filings, Tetragon Partners GP Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 286,990 shares valued at US$13.5M — an increase of 86,996 shares quarter over quarter.. Notable position changes include a 43% increase in Q2 2026 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 199.99K $3.78M New
Q2 2026 286.99K $13.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 189 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Tetragon Partners GP Ltd held DFTX?

Tetragon Partners GP Ltd has disclosed DFTX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Tetragon Partners GP Ltd's current position in DFTX?

As of Q2 2026, Tetragon Partners GP Ltd holds 286.99K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $13.50M, representing 2.20% of its reported portfolio and ranking #5.

Has Tetragon Partners GP Ltd been buying or selling DFTX?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in DFTX. The position peaked in Q2 2026 at 286.99K shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 189 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.